安悦国际控股(08245.HK)拟折让约18.52%增发1.5亿股净筹328万港元
格隆汇8月22日丨安悦国际控股(08245.HK)公告,于2019年8月22日,公司与认购人马梓欣订立认购协议,据此,公司已同意配发及发行,而认购人已同意按认购价认购1.5亿股认购股份。总认购价约330万港元乃根据每股认购股份0.022港元的认购价较8月22日收市价每股股份0.027港元折让约18.52%。
1.5亿股认购股份相当紧随完成后扩大的公司已发行股约3.76%(假设于公告日期至完成期间,公司的已发行股概无变动(发行认购股份除外))。
经扣除认购事项产生的相关费用后,公司于认购事项项下应收所得款项净额估计约为328万港元。公司拟将所得款项净额用于集团的一般营运资金。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.